Table 2 Lung function testing (whole cohort).
unit | asthma (n = 91) | non-asthmatic controls (n = 47) | p-value | |||
---|---|---|---|---|---|---|
value | range | value | range | |||
spirometry | ||||||
FEV1/VC | %pred | 84 ± 14 | 42–112 | 99 ± 7 | 84–115 | <<0.001* |
FEV1/FVC | % | 72 ± 10 | 44–92 | 83 ± 6 | 71–99 | <<0.001* |
FEV1 | %pred | 80 ± 20 | 22–132 | 101 ± 13 | 65–135 | <<0.001* |
VC | %pred | 95 ± 18 | 42–132 | 102 ± 13 | 64–124 | 0.01* |
MEF75 | %pred | 61 ± 27 | 11–122 | 96 ± 25 | 48–162 | <<0.001* |
MEF50 | %pred | 48 ± 26 | 10–127 | 88 ± 27 | 35–170 | <<0.001* |
MEF25 | %pred | 36 ± 23 | 9–107 | 67 ± 28 | 13–141 | <<0.001* |
body plethysmography | ||||||
TLC | %pred | 109 ± 18 | 65–153 | 108 ± 11 | 87–128 | 0.60 |
RV | %pred | 143 ± 51 | 48–451 | 125 ± 27 | 79–201 | <0.01* |
RV/TLC | % | 45 ± 11 | 22–80 | 37 ± 8 | 21–57 | <<0.001* |
FRCpleth | L | 3.4 ± 0.9 | 1.1–6.0 | 3.1 ± 0.5 | 2.3–4.2 | 0.05 |
TLCO/VA | %pred | 88 ± 15 | 62–122 | 96 ± 10 | 80–116 | <0.001* |
TLCO | %pred | 79 ± 16 | 41–125 | 87 ± 10 | 66–108 | <0.001* |
ΔTLCO | %pt | 12 ± 9 | 0–44 | 11 ± 8 | 0–33 | 0.50 |
impulse oscillometry | ||||||
D5–20 | % | 40 ± 41 | 0–265 | 14 ± 11 | 0–47 | <0.001* |
Ax | — | 1.5 ± 1.8 | 0.0–10.8 | 0.3 ± 0.2 | 0.0–1.1 | <0.001* |
Fres | Hz | 19 ± 8 | 6–44 | 11 ± 4 | 3–22 | <0.001* |
multiple breath wash-out | ||||||
LCI2.5 | — | 8.6 ± 1.8 | 5.5–13.6 | 7.0 ± 0.9 | 5.7–8.9 | <0.001* |
LCI5 | — | 6.6 ± 1.3 | 4.5–10.4 | 5.6 ± 0.6 | 4.5–7.0 | <0.001* |
FRCMBW | L | 2.7 ± 0.9 | 1.0–6.1 | 3.1 ± 0.8 | 1.8–4.6 | 0.01* |
Sacin | L−1 | 0.17 ± 0.15 | −0.2-0.65 | 0.07 ± 0.09 | −0.35-0.21 | <0.001* |
Scond | L−1 | 0.06 ± 0.04 | −0.03-0.18 | 0.04 ± 0.04 | −0.07-0.13 | <0.01* |